Bristol-Myers Squibb Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2011
Total Assets: $32.97B
Liabilities Breakdown FY2011
Total Liabilities: $17.10B
Asset Breakdown
Total Assets: $32.97B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $5.78B | 17.5% |
| Accounts Receivable | $2.25B | 6.8% |
| Inventory | $1.38B | 4.2% |
| Property, Plant & Equipment | $4.52B | 13.7% |
| Goodwill | $5.59B | 16.9% |
| Intangible Assets | $3.12B | 9.5% |
| Other Assets | $10.33B | 31.3% |
Liabilities Breakdown
Total Liabilities: $17.10B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.60B | 15.2% |
| Long-Term Debt | $5.38B | 31.4% |
| Other Liabilities | $9.12B | 53.3% |